Completed NA INTERVENTIONAL NCT00174174

Provigil (Modafinil) Study by Taiwan Biotech Co.

A Placebo Control, Double Blind, Cross Over Study of Modafinil in Patients With Narcolepsy

Sponsor: National Taiwan University Hospital

Conditions Cataplexy Excessive Sleepiness Hypersomnolence Narcolepsy Sleep Disorders

Interventions Modafinil

Updated 4 times since 2017 Last updated: Sep 14, 2005 Started: Sep 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cataplexy and Excessive Sleepiness and is currently completed. National Taiwan University Hospital leads this study, which shows 4 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.